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Abstract
Background: Immune responses play a key role in the pathogenesis and progression of polypoidal choroidal
vasculopath (PCV) and age-related macular degeneration (AMD). In this study, we determined the Th cell-associated
immune responses by measuring the cytokine expression of peripheral blood mononuclear cells (PBMC) in both PCV
and neovascular AMD (nAMD) patients.
Methods: Twenty-seven nAMD patients, 33 PCV patients and a gender- and age-matched group of 18 healthy
individuals were involved in this study. The Th-cell cytokine profiles including levels of interferon-gamma (INF-γ),
interleukin (IL)-17A and IL-4 in cultures of PBMCs were determined by enzyme-linked immunosorbent assay (ELISA).
Results: IFN-γ,IL-17A and IL-4 production was significantly increased after stimulation with PHA. The levels of IFN-γ and
IL-4 in PHA-stimulated cultures were higher in PCV and nAMD patients than that in healthy controls (P = 0.038,P = 0.
014), while no difference was found between PCV and nAMD (all P > 0.05). No significant difference in IL-17A level in
PHA-stimulated cultures was found among PCV, nAMD and control groups (P > 0.05).
Conclusions: These findings suggest that circulating IFN-γ and IL-4 producing Th1 and Th2 cells may involve
in the pathogenesis of PCV and nAMD. PCV may have the similar immune responses with nAMD.
Keywords: T-helper cell, Cytokine, Peripheral blood mononuclear cell, Age-related macular degeneration,
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Background
Age-related macular degeneration (AMD) is a leading
cause of irreversible visual disability and blindness
among elderly in developed countries [1]. An ad-
vanced stage of AMD is characterized by choroidal
neovascularization (neovascular AMD, nAMD) or
geographic atrophy. Polypoidal choroidal vasculopath
(PCV) exhibits commonalities with nAMD in that
both are choroidal vasculopathy associated with sub-
retinal hemorrhage, scars and fibrosis [2]. However,
PCV is characterized by inner choroidal vascular
networks ending in polypoidal structures at the bor-
ders of the lesion, while nAMD is characterized by
choroidal neovascularization [3]. PCV still remains a
subject of debate as to whether it is a subtype of
AMD or its own distinct entity. The differences be-
tween the pathogeneses of PCV and nAMD are still
unknown.
Recent information supports the notion that immune
mechanisms play an important and perhaps central role
in the pathogenesis of AMD [4]. CD4+ T cells are key
players in immune responses. Among the T-helper cells,
each subset produces different effector cytokines. Th1
cells predominantly secrete Interferon-gamma (IFN-γ),* Correspondence: sushaobo7836@gmail.com
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Th2 cells primarily produce IL-4 [5], CD4+ Th cells also
produce IL-17, denoted as Th17 cells [6]. It is suggests
that the underlying mechanism leading to AMD is the
decline of the ocular down-regulatory immune environ-
ment [7]. The subsequent activation of the immune sys-
tem would lead to T-cell sensitization. The accumulation
of complement component 5a (C5a) and C3a in drusen
promote choroidal neovascularization (CNV), which is
the hallmark of wet AMD [8]. C5a promotes interleukin
(IL)-22 and IL-17 expression by human CD4+ T cells [9].
IL-17A was initially reported to be mainly expressed by
activated CD4+ T cells. It was implicated in the pathogen-
esis of various autoimmune diseases including uveitis,
arthritis, multiple sclerosis and inflammatory bowel
disease [10]. IL-17A rs2275913G/A and rs3748067C/T
polymorphisms are associated with increased risk of
AMD [11]. IFN-γ, a soluble cytokine associated with
innate and adaptive immunity, is considered to be a
pro-inflammatory factor. Constituents of drusen such
as amyloid beta and advanced glycation endproducts
(AGE) are capable of activating the IFN-γ pathway
[12]. IFN-γ promotes proinflammatory responses by
activating proinflammatory cytokines and chemokines,
thereby recruiting immune cells such as macrophages,
microglia, NK and T cells into inflammatory sites [13, 14].
IFN-γ induces a dose- and time-dependent increase in
complement factor B mRNA expression in primary mac-
rophages and macrophage cell lines [15] and increases
CXCL11 mRNA expression and CXCL11 protein secre-
tion by ARPE-19 cells [16]. IFN-γ also induces VEGF ex-
pression in human retinal pigment epithelial cells.
Unexpectedly, IFNγ-induced VEGF secretion in human
retinal pigment epithelial cells (RPE) was not through the
classic IFN-γ Jak/Stat1 pathway, but through the PI-
3 K/mTOR/p70-S6K-translational regulation pathway
[17]. In laser-induced CNV model, NK cell depletion
leads to decreased areas of CNV, macrophage infiltra-
tion and reduced mRNA expression of VEGFs and
IFN-γ in the choroid, suggesting that IFN-γ-secreting
NK cells promote angiogenesis by enhancing VEGF
expression via macrophage activation [18]. IFN-γ may
involve in AMD pathogenesis through macrophage
polarization. INF-γ can selectively promote polarization
into M1 subtype [19]. M1 subtype is predominantly proin-
flammatory and there is a pathological shift towards M1
subtype with the development of AMD [13].
Although IFN-γ and IL-17 are shown to be the major
product of inflammasome cascade activation, few study
focus on the immune-inflammatory response of PCV.
The Th-cytokine levels of PCV and nAMD in peripheral
blood mononuclear cells (PBMCs) have not been previ-
ously studied. In the present study, we studied the pro-
duction of IFN-γ, IL-17A, and IL-4 in cultures of
PBMCs from PCV and nAMD patients.
Methods
Subjects and sample preparation
Twenty-seven nAMD patients, 33 PCV patients and a
gender- and age-matched group of 18 healthy individ-
uals were selected from the Outpatient Clinics at the
Zhongshan Ophthalmic Centre for the study. In-
formed consent was obtained from all patients and
controls before entering the study. Research was per-
formed in accordance with the ethical standards of
the Declaration of Helsinki and the internal Ethics
Committees of Sun Yat-sen University, Guangzhou,
China, which approved all of the protocols.
Only patients without infectious diseases and not
using immunosuppressive drugs were enrolled in the
study. Moreover, patients with other neovascularized
maculopathies, such as pathologic myopia, angioid
streaks, and retinal angiomatous proliferation were ex-
cluded. Patients with media opacities preventing clear
visualization of the macula were excluded from the
study. Patients received intravitreal anti-vascular endo-
thelial growth factor (VEGF) therapy were also excluded
from the study.
The diagnosis of PCV was based on identification of
characteristic polypoidal choroidal vascular dilations
with or without branching inner choroidal vessels on
ICGA. All PCV patients enrolled in this study met the
criteria of definitive cases of PCV, as proposed by the
Japanese Study Group of PCV [20]. Cases diagnosed as
probable were excluded because they were difficult to
distinguish from AMD cases. The diagnosis of nAMD
was based on identification of choroidal neovasculariza-
tion by fluorescein angiography and ICGA. All nAMD
cases were classified as stage 4 by the Rotterdam Study
classification [21].
A whole-blood (12 ml) sample was taken from each
study participant and placed in a sterile tube containing
lithium heparin as anticoagulant (Vacutainer, BD) for
the cell proliferation test and cytokine.
Cell isolation and culture
The PBMCs were prepared from heparinized blood by
Ficoll-Hypaque density-gradient centrifugation. To study
the production of IFN-γ, IL-17 and IL-4, PBMCs were
stimulated with PHA at a density of 2 × 106 cells/ml. Iso-
lated PBMCs were stimulated for 48 h and subsequently
used for IFN-γ, IL-17 and IL-4 analysis by ELISA.
ELISA for IFN-γ, IL-17 and IL-4
The protein levels of IFN-γ, IL-17 and IL-4 in the col-
lected supernatants were measured using a Duoset
ELISA development kit (R&D Systems). The minimal
detectable concentration was 15 pg/ml for IFN-γ, IL-17
and IL-4. All samples were measured in duplicate.
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Statistical analysis
All analyses were performed using the Statistical Package
for the Social Sciences statistical software for Windows,
version 17.0 (SPSS Inc.). Group differences among dia-
betics and controls were analyzed using one-way
ANOVA or nonparametric Kruskal–Wallis tests, de-
pending on normality assumptions and the homogeneity
of variances. The parameters showing statistically signifi-
cant differences among all groups were further analyzed
using the Mann–Whitney-U test or Student’s t-test. Dif-
ferences within groups before and after stimulation were
analyzed by Wilcoxon test. The correlations among
study parameters were analyzed by Spearman’s correl-
ation test. Differences in baseline gender among cases
and controls were assessed using χ2 tests for propor-
tions. For all tests, P values < 0.05 were considered sta-
tistically significant. Graphs were prepared by using
Prism version 5 (GraphPad Software Inc., La Jolla, USA).
Results
Clinical characteristics of the patients
The clinical characteristics of the enrolled patients are
shown in Table 1. With regard to age, sex, and body mass
index (BMI) distribution, no significant difference was ob-
served between the study groups (P = 0.945, P = 0.966, P =
0.177, respectively) (Table 1). Six patients were hyperten-
sive in nAMD group and 7 patients were hypertensive in
PCV. Twenty-five eyes had drusen in nAMD and only 6
eyes in PCV. Eight eyes had a pigment epithelium detach-
ment (PED) in nAMD and 17 eyes in PCV. Subretinal fi-
brosis was present at a variable severity in 8 eyes in
nAMD and 3 eyes in PCV.
Concentrations of IFN-γ,IL-17A and IL-4 in the supernatants
of cultured PBMCs
The results showed that IFN-γ and IL-4 was un-
detectable in the supernatants of unstimulated PBMCs
of all subjects. A low concentration of IL-17A was
detected in the supernatants of unstimulated PBMCs
of patients with PCV and nAMD and control sub-
jects, no significant difference was found among three
groups (P = 0.436) (Table 2).
After stimulation with PHA, IFN-γ, IL-17A and IL-4
production were significantly increased. The concentra-
tion of IFN-γ was 341.37 ± 341.96 pg/ml in PCV PBMCs
samples and 393.42 ± 404.35 pg/ml in nAMD PBMCs
samples. The concentration of IL-17A was 1218.08 ±
860.30 pg/ml in PCV PBMCs samples and 942.09 ±
570.23 pg/ml in nAMD. At the same time, the concen-
tration of IL-4 was 42.08 ± 83.97 pg/ml in PCV PBMCs
samples and 29.53 ± 69.46 pg/ml in nAMD PBMCs sam-
ples (Table 3).
IFN-γ and IL-4 levels were markedly elevated in the PCV
and nAMD
The IFN-γ levels in PHA-stimulated cultures were
higher in PCV and nAMD patients than that in healthy
controls (P = 0.038,P = 0.014), while no difference was
found between PCV and nAMD (P = 0.556) (Fig. 1). The
IL-4 levels in PHA-stimulated cultures were higher in
PCV and nAMD patients than that in healthy controls
(P = 0.008, P = 0.003), while no difference was found be-
tween PCV and nAMD (P = 0.981). (Fig. 2). No signifi-
cant difference in IL-17A levels in PHA-stimulated
cultures were found among PCV, nAMD and control
groups (P = 0.335) (Table 3).
Correlation analyses in PCV and nAMD
The IFN-γ concentration was positively correlated
with IL-4 concentration in activated PBMCs both in
PCV and nAMD group (r = 0.394, P = 0.026 and r =
0.563, P = 0.003, respectively; Figs. 3 and 4). We
found no correlation between IL-17A and IFN-γ con-
centrations in PCV and nAMD group (r = 0.051, P =
0.782; r = -0.092, P = 0.661).
Discussion
There is more and more evidence for immune re-
sponse involve in the pathogenesis and progression
of AMD. Retinal pigment epithelial (RPE) cell is one
of the most important systems that regulate the im-
mune response in the eye. RPE cell represents a pri-
mary site of pathology in AMD and their function
and phenotype may modify by cytokines and inflam-
matory mediators. Dysfunction of RPE cells could
trigger the inflammatory response, which then could
trigger the photoreceptor degeneration and neovascu-
larization in the retinas [22]. This might be one of
the mechanisms of PCV and nAMD development. A
few data on these immuno-inflammatory cytokines
expression in PCV were reported. We therefore ex-
amined the levels of Th cytokines of PCV and
nAMD patients. Our result showed that IFN-γ levels
in the supernatants of cultured PBMCs in PCV and
nAMD patients were markedly elevated compared
with normal controls, indicating that IFN-γ related
Table 1 Clinical and biochemical characteristics of PCV, nAMD
and control subjects
Control subjects PCV nAMD P
Number 18 33 27 0.945
Sex (m/f) 12/8 17/12 12/8 0.945
Age (years) 64.38 ± 11.92 64.79 ± 9.35 64.15 ± 9.30 0.966
BMI (kg/m2) 23.17 ± 2.02 21.21 ± 2.20 23.21 ± 3.64 0.177
BMI Body mass index, PCV polypoidal choroidal vasculopathy, nAMD
neovascular age-related macular degeneration
Data are expressed as mean ± SD
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inflammatory pathway may involve in the pathogen-
esis of PCV and nAMD.
Recent studies point towards an emerging relationship
between IFN-γ and mechanisms underlying the patho-
genesis of AMD. The interaction of pathways activated
by IFN-γ is complex and not fully understood. IFN-γ is
classically considered as a pro-inflammatory factor, yet
in recent years, multiple studies find IFN-γ to mediate
an immune-modulatory and protective function. IFN-γ
increases complement factor H (CFH) expression in cul-
tured human RPE [23]. CFH is a major inhibitor of the
alternative complement activation pathway that plays a
critical role in driving the inflammatory responses in
outer retina and is associated with AMD pathogenesis
[24]. In human endothelial cells IFN-γ inhibits the an-
giogenic activity of VEGF through activation of STAT1
pathway. This may inhibit excess angiogenesis process in
wet AMD [25]. Another study suggests that IFN-γ in-
duces VEGF expression in human retinal pigment epi-
thelial cells [17]. The activation of the PI-3 K/mTOR/
translational pathway is important for IFN-γ-mediated
VEGF expression in RPE cells. It is known that STAT1-
deficient mouse are highly susceptible to autoimmune
disorders, thus STAT1 activation by IFN-γ may be im-
portant in mitigating AMD progression [13].
IFN-γ may also play a beneficial role by regulating
Th17 cells. IL-17A is an important cytokine implicated
in the pathogenesis of autoimmune disease [26]. Our
data indicate that no significant difference in IL-17A
levels in PHA-stimulated cultures among PCV, nAMD
and control groups. It is reported that in vitro stimulated
PBMCs carrying rs2275913AA genotype produced sig-
nificantly more IL-17 than those with the GG genotype,
and similar data were observed in both controls and
AMD patients [11]. In paraffin-embedded tissues, ex-
pression of IL17A mRNA and the receptor IL17RC
mRNA are higher in the macula of AMD patients than
in control [27]. In vitro, IL17A induces RPE cell death
characterized by the accumulation of cytoplasmic lipids
and autophagosomes with subsequent activation of pro-
apoptotic Caspase-3 and Caspase-9 [27]. Aqueous
humor levels of IL-17 in eyes with nAMD or PCV are
not statistically different from those in control eyes [28].
This result is consistent with our results. The different
results are owing to different sample tissue, target popu-
lation, detection mean and so on. Further studies are
needed to clarify the role of Th17 in these patients.
In our analyses of serum cytokine profiles, IL-4 level
in PHA-stimulated cultures was higher in PCV and
nAMD patients than that in healthy controls. IL-4, a
cytokine of Th2 subtype, plays an important role in
humoral and cell-mediated immunity [29]. AGEs are a
constituent of drusen and accumulate in Bruch’s mem-
brane with age. IL-4 in supernatant samples from AGE
Table 2 Concentrations of IL-17A in culture supernatants of unstimulated or activated PBMCs from PCV, nAMD and healthy controls
PBMCs Control subjects PCV nAMD p
(N = 18) (N = 33) (N = 27)
IL-17A (unstimulated) 20.61 ± 45.23 45.25 ± 65.76 46.01 ± 65.76 0.436
(stimulated) 1215.53 ± 875.21 1218.08 ± 860.30 942.09 ± 570.23 0.335
Z -3.724 -3.621 -2.934
P 0.000 0.000 0.003
PCV polypoidal choroidal vasculopathy, nAMD neovascular age-related macular degeneration
All cytokines expressed as pg/ml. Data are means ± SD
Table 3 Concentrations of IFN-γ, IL-17A and IL-4 in culture
supernatants of activated PBMCs from PCV, nAMD and healthy
controls
Control subjects PCV nAMD p
(N = 18) (N = 33) (N = 27)
IFN-γ 135.90 ± 130.61 341.37 ± 341.96 393.42 ± 404.35 0.037
IL-17A 1215.53 ± 875.21 1218.08 ± 860.30 942.09 ± 570.23 0.335
IL-4 7.34 ± 23.24 42.08 ± 83.97 29.53 ± 69.46 0.012
PCV polypoidal choroidal vasculopathy, nAMD neovascular age-related
macular degeneration
All cytokines expressed as pg/ml. Data are means ± SD
Fig. 1 IFN-γ levels in the supernatants of cultured PBMCs measured
by ELISA. Separated PBMCs were cultured with PHA (0.02 %) for 48 h.
Data are represented as means ± SME
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stimulation of human RPE cells is 5.5 fold changes over
controls [30]. Aqueous humor levels of IL-4 in eyes with
nAMD or PCV are not statistically different from those
in control eyes [28]. The levels of IL-4 in the aqueous
humor samples from PCV patients are significantly
higher than in the controls.
However, we were unable to distinguish nAMD and
PCV from PHA-stimulated PBMCs based the expres-
sion of IFN-γ and IL-4. The reason remains unclear
as the number of subjects enrolled in our present
study was limited. One possibility is that IFN-γ and
IL-4 is upregulated in both PCV and nAMD condi-
tions but with different level and time window which
may further trigger different signaling pathways and
lead to different abnormal angiogenesis process. Another
possibility is that PCV may have similar immune character
with nAMD. PCV has many similarities with neovascular
AMD, including clinical manifestations, genetic back-
ground, and epidemiological features [28]. It remains con-
troversial as to whether or not PCV represents a subtype
of nAMD. In clinical, some patients have possibility hav-
ing CNV we cannot distinguish PCV from neovascular
AMD. ‘Probable’ cases were determined if at least one of
the following criteria were met: 1. only an abnormal vas-
cular network is seen in ICGA. 2. Recurrent hemorrhagic
and/or serous detachments of the RPE were observed [2].
From view of immune character, aqueous humor concen-
trations of CRP and IP-10 were elevated in eyes with PCV
or nAMD. None of the 14 cytokines, including VEGF, IL-
1α, IL-2, IL-4, IL-6, IL-8, IL-10, IL-12, IL-13, IL-15, IL-17,
monocyte chemoattractant protein 1, were significantly
different between eyes with nAMD and those with PCV
[28]. It is reported that PCV and nAMD have common as-
sociations with the complement factor H (CFH) and the
HtrA serine peptidase 1 (HTRA1) genes [31, 32], which
suggests some genetic similarity between these two en-
tities. ARMS2/HTRA1 locus has a strong and consistent
association with both exudative AMD and PCV, suggest-
ing the two disorders share, at least partially, similar mo-
lecular mechanisms [33].
In our previous study, we identified a variant in
chromosome 9p21, well known to be associated with
coronary artery disease and type 2 diabetes, was signifi-
cantly associated with PCV but not with neovascular
AMD in the Chinese Han population [34]. The rs42524
polymorphism is a risk allele for nAMD in a Han Chinese
population [35]. However, rs42524 in COL1A2 confers
different levels of susceptibility to nAMD and PCV [35]
Thus, the different role of IFN-γ and IL-4 in the
Fig. 2 IL-4 levels in the supernatants of cultured PBMCs measured
by ELISA. Separated PBMCs were cultured with PHA (0.02 %) for
48 h. Data are represented as means ± SME
Fig. 3 Correlation between IFN-γ and IL-4 in the supernatants of
active PBMCs from PCV groups. The Spearman correlation test was
used (P < 0.05 significant; r = correlation coefficient)
Fig. 4 Correlation between IFN-γ and IL-4 in the supernatants of
active PBMCs from nAMD groups. The Spearman correlation test
was used (P < 0.05 significant; r = correlation coefficient)
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development of PCV and nAMD needs to be verified in
further studies.
The major limitation of this study is the relatively
small sample size. Additionally, no mechanistic and
functional evaluations were conducted in this study.
Extended cohorts with both PCV and nAMD patients
offering higher statistical power will be necessary to
confirm our results.
Conclusion
In summary, our data show that circulating IFN-γ-
producing Th1 cells and IL-4-producing Th2 cells is as-
sociated with the pathogenesis of PCV and nAMD.
There is no significant difference in IFN-γ, IL-17A and
IL-4 levels in the supernatants of cultured PBMCs be-
tween PCV and nAMD, indicating PCV may have the
similar immune character with nAMD.
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